高级检索
当前位置: 首页 > 详情页

Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE1): A Study Protocol of a Non-Interventional Registry Study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Beijing Chao-Yang Hospital, Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China [2]Chinese PLA General Hospital, Haidian District, Beijing, China [3]National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Yinghua Dongjie, Hepingli, Beijing, China
出处:
ISSN:

关键词: Deep vein thrombosis Pulmonary embolism Thrombocytopenia Thromboprophylaxis Venous thromboembolism

摘要:
IntroductionVenous thromboembolism (VTE) is a frequent cause of hospitalization, mortality, and long-term adverse consequence among medical and surgical inpatients. The current study is performed to identify the prophylaxis of patients with VTE risk within the 6weeks prior to the diagnosis of VTE, and the treatment pattern during 3months after VTE diagnosis in Chinese patients hospitalized for surgeries or medical illness.MethodsThis multicenter, non-interventional, observational registry plans to enroll 1200 patients from 40 centers in China. The study will retrospectively collect data from patients' hospitalization record within 6weeks of VTE diagnosis and prospectively follow-up patients for 3months (in four visits). The primary outcome is to determine the percentage of patients receiving adequate prophylaxis in patients hospitalized within 6weeks before VTE diagnosis and treatment pattern within 3months after VTE diagnosis. Important secondary endpoints include determining patients with risk of VTE in the hospital setting, risk factors for VTE, and cost analysis of VTE treatment.Expected OutcomesThe findings will determine the characteristics of VTE, its treatment practices, cost of treatment, and quality of life in patients; this information may help in building diagnostic and prophylaxis strategies for VTE in China.Trial RegistrationThe study is registered in the Venous Thromboembolism Registry in China with study number DIREGL07581.FundingSanofi China.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 3 区 药学
最新[2025]版:
大类 | 3 区 医学
小类 | 2 区 药学 3 区 医学:研究与实验
JCR分区:
出版当年[2017]版:
Q2 PHARMACOLOGY & PHARMACY Q2 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2017版] 出版当年五年平均[2013-2017] 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Beijing Chao-Yang Hospital, Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)